nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—SHBG—type 2 diabetes mellitus	0.39	0.744	CbGaD
Etonogestrel—CYP3A4—type 2 diabetes mellitus	0.135	0.256	CbGaD
Etonogestrel—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0367	0.152	CbGbCtD
Etonogestrel—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0327	0.136	CbGbCtD
Etonogestrel—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0299	0.124	CbGbCtD
Etonogestrel—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0262	0.109	CbGbCtD
Etonogestrel—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0237	0.0982	CbGbCtD
Etonogestrel—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0179	0.0744	CbGbCtD
Etonogestrel—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0172	0.0713	CbGbCtD
Etonogestrel—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0172	0.0713	CbGbCtD
Etonogestrel—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0163	0.0675	CbGbCtD
Etonogestrel—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0121	0.0503	CbGbCtD
Etonogestrel—CYP3A4—Losartan—type 2 diabetes mellitus	0.0111	0.046	CbGbCtD
Etonogestrel—SHBG—hindlimb—type 2 diabetes mellitus	0.00156	0.322	CbGeAlD
Etonogestrel—PGR—artery—type 2 diabetes mellitus	0.000863	0.178	CbGeAlD
Etonogestrel—Levonorgestrel—SRD5A1—type 2 diabetes mellitus	0.000739	0.136	CrCbGaD
Etonogestrel—Desogestrel—SHBG—type 2 diabetes mellitus	0.000437	0.0805	CrCbGaD
Etonogestrel—Nandrolone phenpropionate—AR—type 2 diabetes mellitus	0.000435	0.0801	CrCbGaD
Etonogestrel—Danazol—CCL2—type 2 diabetes mellitus	0.0004	0.0737	CrCbGaD
Etonogestrel—SHBG—cardiovascular system—type 2 diabetes mellitus	0.000333	0.0687	CbGeAlD
Etonogestrel—Nandrolone decanoate—AR—type 2 diabetes mellitus	0.00033	0.0607	CrCbGaD
Etonogestrel—Norgestimate—ABCC2—type 2 diabetes mellitus	0.000319	0.0587	CrCbGaD
Etonogestrel—PGR—cardiovascular system—type 2 diabetes mellitus	0.0003	0.0619	CbGeAlD
Etonogestrel—SHBG—adipose tissue—type 2 diabetes mellitus	0.000294	0.0606	CbGeAlD
Etonogestrel—PGR—adipose tissue—type 2 diabetes mellitus	0.000264	0.0546	CbGeAlD
Etonogestrel—Levonorgestrel—SHBG—type 2 diabetes mellitus	0.00025	0.0461	CrCbGaD
Etonogestrel—ESR1—cardiovascular system—type 2 diabetes mellitus	0.000235	0.0484	CbGeAlD
Etonogestrel—ESR1—kidney—type 2 diabetes mellitus	0.00023	0.0474	CbGeAlD
Etonogestrel—Danazol—SHBG—type 2 diabetes mellitus	0.000228	0.042	CrCbGaD
Etonogestrel—Levonorgestrel—AR—type 2 diabetes mellitus	0.000219	0.0404	CrCbGaD
Etonogestrel—Ethinyl Estradiol—SHBG—type 2 diabetes mellitus	0.000211	0.0388	CrCbGaD
Etonogestrel—ESR1—adipose tissue—type 2 diabetes mellitus	0.000207	0.0427	CbGeAlD
Etonogestrel—SHBG—liver—type 2 diabetes mellitus	0.000206	0.0425	CbGeAlD
Etonogestrel—Norethindrone—SHBG—type 2 diabetes mellitus	0.000203	0.0373	CrCbGaD
Etonogestrel—Danazol—AR—type 2 diabetes mellitus	0.0002	0.0368	CrCbGaD
Etonogestrel—Methyltestosterone—SHBG—type 2 diabetes mellitus	0.000193	0.0355	CrCbGaD
Etonogestrel—Methyltestosterone—AR—type 2 diabetes mellitus	0.000169	0.0311	CrCbGaD
Etonogestrel—Ethinyl Estradiol—ABCC2—type 2 diabetes mellitus	0.000165	0.0303	CrCbGaD
Etonogestrel—Testosterone—CYP11A1—type 2 diabetes mellitus	0.000159	0.0292	CrCbGaD
Etonogestrel—ESR1—liver—type 2 diabetes mellitus	0.000145	0.0299	CbGeAlD
Etonogestrel—CYP3A4—kidney—type 2 diabetes mellitus	0.000128	0.0264	CbGeAlD
Etonogestrel—Back pain—Losartan—type 2 diabetes mellitus	0.000118	0.000646	CcSEcCtD
Etonogestrel—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000118	0.000646	CcSEcCtD
Etonogestrel—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000118	0.000646	CcSEcCtD
Etonogestrel—Anorexia—Valsartan—type 2 diabetes mellitus	0.000118	0.000642	CcSEcCtD
Etonogestrel—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000118	0.000642	CcSEcCtD
Etonogestrel—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000641	CcSEcCtD
Etonogestrel—Myalgia—Metformin—type 2 diabetes mellitus	0.000117	0.00064	CcSEcCtD
Etonogestrel—Malaise—Irbesartan—type 2 diabetes mellitus	0.000117	0.00064	CcSEcCtD
Etonogestrel—Headache—Pioglitazone—type 2 diabetes mellitus	0.000117	0.000637	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000116	0.000636	CcSEcCtD
Etonogestrel—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000116	0.000634	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000116	0.000633	CcSEcCtD
Etonogestrel—Discomfort—Metformin—type 2 diabetes mellitus	0.000116	0.000633	CcSEcCtD
Etonogestrel—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000116	0.000632	CcSEcCtD
Etonogestrel—Nausea—Glipizide—type 2 diabetes mellitus	0.000116	0.00063	CcSEcCtD
Etonogestrel—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000115	0.00063	CcSEcCtD
Etonogestrel—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000115	0.000628	CcSEcCtD
Etonogestrel—Constipation—Gliclazide—type 2 diabetes mellitus	0.000115	0.000627	CcSEcCtD
Etonogestrel—Pain—Gliclazide—type 2 diabetes mellitus	0.000115	0.000627	CcSEcCtD
Etonogestrel—Rash—Glimepiride—type 2 diabetes mellitus	0.000114	0.000625	CcSEcCtD
Etonogestrel—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000114	0.000624	CcSEcCtD
Etonogestrel—Rash—Sitagliptin—type 2 diabetes mellitus	0.000114	0.000623	CcSEcCtD
Etonogestrel—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000114	0.000622	CcSEcCtD
Etonogestrel—Headache—Glimepiride—type 2 diabetes mellitus	0.000114	0.000621	CcSEcCtD
Etonogestrel—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000114	0.00062	CcSEcCtD
Etonogestrel—Cough—Irbesartan—type 2 diabetes mellitus	0.000113	0.000619	CcSEcCtD
Etonogestrel—Headache—Sitagliptin—type 2 diabetes mellitus	0.000113	0.000619	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000112	0.000614	CcSEcCtD
Etonogestrel—Oedema—Metformin—type 2 diabetes mellitus	0.000112	0.000614	CcSEcCtD
Etonogestrel—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000112	0.000613	CcSEcCtD
Etonogestrel—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000112	0.000611	CcSEcCtD
Etonogestrel—Angioedema—Losartan—type 2 diabetes mellitus	0.000112	0.00061	CcSEcCtD
Etonogestrel—Testosterone—SHBG—type 2 diabetes mellitus	0.000112	0.0206	CrCbGaD
Etonogestrel—Infection—Metformin—type 2 diabetes mellitus	0.000112	0.00061	CcSEcCtD
Etonogestrel—Insomnia—Valsartan—type 2 diabetes mellitus	0.000112	0.00061	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000111	0.000607	CcSEcCtD
Etonogestrel—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000111	0.000605	CcSEcCtD
Etonogestrel—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000111	0.000604	CcSEcCtD
Etonogestrel—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000111	0.000604	CcSEcCtD
Etonogestrel—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000111	0.000604	CcSEcCtD
Etonogestrel—Insomnia—Orlistat—type 2 diabetes mellitus	0.00011	0.000602	CcSEcCtD
Etonogestrel—Malaise—Losartan—type 2 diabetes mellitus	0.00011	0.000602	CcSEcCtD
Etonogestrel—Anxiety—Irbesartan—type 2 diabetes mellitus	0.00011	0.000602	CcSEcCtD
Etonogestrel—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00011	0.000602	CcSEcCtD
Etonogestrel—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00011	0.000602	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00011	0.0006	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00011	0.0006	CcSEcCtD
Etonogestrel—Somnolence—Valsartan—type 2 diabetes mellitus	0.00011	0.000599	CcSEcCtD
Etonogestrel—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00011	0.000598	CcSEcCtD
Etonogestrel—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000109	0.000597	CcSEcCtD
Etonogestrel—Skin disorder—Metformin—type 2 diabetes mellitus	0.000109	0.000596	CcSEcCtD
Etonogestrel—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000109	0.000594	CcSEcCtD
Etonogestrel—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000109	0.000593	CcSEcCtD
Etonogestrel—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000108	0.000591	CcSEcCtD
Etonogestrel—Nausea—Glimepiride—type 2 diabetes mellitus	0.000108	0.000588	CcSEcCtD
Etonogestrel—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000107	0.000586	CcSEcCtD
Etonogestrel—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000107	0.000586	CcSEcCtD
Etonogestrel—Asthenia—Glyburide—type 2 diabetes mellitus	0.000107	0.000586	CcSEcCtD
Etonogestrel—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000107	0.000586	CcSEcCtD
Etonogestrel—Anorexia—Metformin—type 2 diabetes mellitus	0.000107	0.000585	CcSEcCtD
Etonogestrel—Cough—Losartan—type 2 diabetes mellitus	0.000107	0.000583	CcSEcCtD
Etonogestrel—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000107	0.000583	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000107	0.000582	CcSEcCtD
Etonogestrel—Alopecia—Ramipril—type 2 diabetes mellitus	0.000106	0.000581	CcSEcCtD
Etonogestrel—Fatigue—Valsartan—type 2 diabetes mellitus	0.000106	0.000581	CcSEcCtD
Etonogestrel—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000106	0.00058	CcSEcCtD
Etonogestrel—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000106	0.00058	CcSEcCtD
Etonogestrel—Oedema—Irbesartan—type 2 diabetes mellitus	0.000106	0.000579	CcSEcCtD
Etonogestrel—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000106	0.000579	CcSEcCtD
Etonogestrel—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000106	0.000579	CcSEcCtD
Etonogestrel—Pruritus—Glyburide—type 2 diabetes mellitus	0.000106	0.000578	CcSEcCtD
Etonogestrel—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000106	0.000576	CcSEcCtD
Etonogestrel—Constipation—Valsartan—type 2 diabetes mellitus	0.000106	0.000576	CcSEcCtD
Etonogestrel—Infection—Irbesartan—type 2 diabetes mellitus	0.000105	0.000575	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000105	0.000575	CcSEcCtD
Etonogestrel—Fatigue—Orlistat—type 2 diabetes mellitus	0.000105	0.000574	CcSEcCtD
Etonogestrel—Erythema—Ramipril—type 2 diabetes mellitus	0.000105	0.000573	CcSEcCtD
Etonogestrel—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000105	0.000573	CcSEcCtD
Etonogestrel—Pain—Orlistat—type 2 diabetes mellitus	0.000104	0.000569	CcSEcCtD
Etonogestrel—Myalgia—Losartan—type 2 diabetes mellitus	0.000104	0.000569	CcSEcCtD
Etonogestrel—Arthralgia—Losartan—type 2 diabetes mellitus	0.000104	0.000569	CcSEcCtD
Etonogestrel—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000568	CcSEcCtD
Etonogestrel—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000104	0.000568	CcSEcCtD
Etonogestrel—Anxiety—Losartan—type 2 diabetes mellitus	0.000104	0.000567	CcSEcCtD
Etonogestrel—Rash—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000563	CcSEcCtD
Etonogestrel—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000563	CcSEcCtD
Etonogestrel—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000103	0.000563	CcSEcCtD
Etonogestrel—Tension—Ramipril—type 2 diabetes mellitus	0.000103	0.000562	CcSEcCtD
Etonogestrel—Discomfort—Losartan—type 2 diabetes mellitus	0.000103	0.000562	CcSEcCtD
Etonogestrel—Headache—Bromocriptine—type 2 diabetes mellitus	0.000103	0.00056	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000102	0.000559	CcSEcCtD
Etonogestrel—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000102	0.000559	CcSEcCtD
Etonogestrel—Nervousness—Ramipril—type 2 diabetes mellitus	0.000102	0.000556	CcSEcCtD
Etonogestrel—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000101	0.000552	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000101	0.000551	CcSEcCtD
Etonogestrel—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000101	0.000551	CcSEcCtD
Etonogestrel—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000101	0.000551	CcSEcCtD
Etonogestrel—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000101	0.000549	CcSEcCtD
Etonogestrel—Somnolence—Metformin—type 2 diabetes mellitus	0.0001	0.000546	CcSEcCtD
Etonogestrel—Anaphylactic shock—Losartan—type 2 diabetes mellitus	9.99e-05	0.000545	CcSEcCtD
Etonogestrel—Oedema—Losartan—type 2 diabetes mellitus	9.99e-05	0.000545	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	9.98e-05	0.000545	CcSEcCtD
Etonogestrel—Infection—Losartan—type 2 diabetes mellitus	9.92e-05	0.000541	CcSEcCtD
Etonogestrel—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.9e-05	0.00054	CcSEcCtD
Etonogestrel—Dyspepsia—Metformin—type 2 diabetes mellitus	9.9e-05	0.00054	CcSEcCtD
Etonogestrel—Urticaria—Valsartan—type 2 diabetes mellitus	9.81e-05	0.000535	CcSEcCtD
Etonogestrel—Testosterone—AR—type 2 diabetes mellitus	9.8e-05	0.018	CrCbGaD
Etonogestrel—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.79e-05	0.000535	CcSEcCtD
Etonogestrel—Decreased appetite—Metformin—type 2 diabetes mellitus	9.77e-05	0.000533	CcSEcCtD
Etonogestrel—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.76e-05	0.000533	CcSEcCtD
Etonogestrel—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.73e-05	0.000531	CcSEcCtD
Etonogestrel—Nausea—Bromocriptine—type 2 diabetes mellitus	9.72e-05	0.000531	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.71e-05	0.00053	CcSEcCtD
Etonogestrel—Fatigue—Metformin—type 2 diabetes mellitus	9.69e-05	0.000529	CcSEcCtD
Etonogestrel—Urticaria—Orlistat—type 2 diabetes mellitus	9.69e-05	0.000529	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.67e-05	0.000528	CcSEcCtD
Etonogestrel—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.64e-05	0.000526	CcSEcCtD
Etonogestrel—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.64e-05	0.000526	CcSEcCtD
Etonogestrel—Asthenia—Gliclazide—type 2 diabetes mellitus	9.64e-05	0.000526	CcSEcCtD
Etonogestrel—Constipation—Metformin—type 2 diabetes mellitus	9.62e-05	0.000525	CcSEcCtD
Etonogestrel—Angioedema—Ramipril—type 2 diabetes mellitus	9.59e-05	0.000523	CcSEcCtD
Etonogestrel—Paraesthesia—Irbesartan—type 2 diabetes mellitus	9.53e-05	0.00052	CcSEcCtD
Etonogestrel—Anorexia—Losartan—type 2 diabetes mellitus	9.52e-05	0.00052	CcSEcCtD
Etonogestrel—Vomiting—Glyburide—type 2 diabetes mellitus	9.52e-05	0.000519	CcSEcCtD
Etonogestrel—Pruritus—Gliclazide—type 2 diabetes mellitus	9.51e-05	0.000519	CcSEcCtD
Etonogestrel—Malaise—Ramipril—type 2 diabetes mellitus	9.46e-05	0.000516	CcSEcCtD
Etonogestrel—Rash—Glyburide—type 2 diabetes mellitus	9.44e-05	0.000515	CcSEcCtD
Etonogestrel—Somnolence—Irbesartan—type 2 diabetes mellitus	9.43e-05	0.000515	CcSEcCtD
Etonogestrel—Dermatitis—Glyburide—type 2 diabetes mellitus	9.43e-05	0.000515	CcSEcCtD
Etonogestrel—Headache—Glyburide—type 2 diabetes mellitus	9.38e-05	0.000512	CcSEcCtD
Etonogestrel—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.34e-05	0.00051	CcSEcCtD
Etonogestrel—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.27e-05	0.000506	CcSEcCtD
Etonogestrel—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.22e-05	0.000503	CcSEcCtD
Etonogestrel—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.19e-05	0.000502	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.19e-05	0.000502	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.0005	CcSEcCtD
Etonogestrel—Cough—Ramipril—type 2 diabetes mellitus	9.16e-05	0.0005	CcSEcCtD
Etonogestrel—Fatigue—Irbesartan—type 2 diabetes mellitus	9.15e-05	0.000499	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.1e-05	0.000497	CcSEcCtD
Etonogestrel—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.1e-05	0.000497	CcSEcCtD
Etonogestrel—Convulsion—Ramipril—type 2 diabetes mellitus	9.09e-05	0.000496	CcSEcCtD
Etonogestrel—Constipation—Irbesartan—type 2 diabetes mellitus	9.07e-05	0.000495	CcSEcCtD
Etonogestrel—Pain—Irbesartan—type 2 diabetes mellitus	9.07e-05	0.000495	CcSEcCtD
Etonogestrel—Insomnia—Losartan—type 2 diabetes mellitus	9.03e-05	0.000493	CcSEcCtD
Etonogestrel—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.99e-05	0.000491	CcSEcCtD
Etonogestrel—Paraesthesia—Losartan—type 2 diabetes mellitus	8.97e-05	0.000489	CcSEcCtD
Etonogestrel—Urticaria—Metformin—type 2 diabetes mellitus	8.93e-05	0.000488	CcSEcCtD
Etonogestrel—Myalgia—Ramipril—type 2 diabetes mellitus	8.93e-05	0.000488	CcSEcCtD
Etonogestrel—Arthralgia—Ramipril—type 2 diabetes mellitus	8.93e-05	0.000488	CcSEcCtD
Etonogestrel—Anxiety—Ramipril—type 2 diabetes mellitus	8.9e-05	0.000486	CcSEcCtD
Etonogestrel—Nausea—Glyburide—type 2 diabetes mellitus	8.89e-05	0.000485	CcSEcCtD
Etonogestrel—Abdominal pain—Metformin—type 2 diabetes mellitus	8.89e-05	0.000485	CcSEcCtD
Etonogestrel—Dizziness—Gliclazide—type 2 diabetes mellitus	8.89e-05	0.000485	CcSEcCtD
Etonogestrel—Somnolence—Losartan—type 2 diabetes mellitus	8.88e-05	0.000485	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	8.87e-05	0.000484	CcSEcCtD
Etonogestrel—Asthenia—Valsartan—type 2 diabetes mellitus	8.86e-05	0.000484	CcSEcCtD
Etonogestrel—Discomfort—Ramipril—type 2 diabetes mellitus	8.82e-05	0.000482	CcSEcCtD
Etonogestrel—Dyspepsia—Losartan—type 2 diabetes mellitus	8.79e-05	0.00048	CcSEcCtD
Etonogestrel—Asthenia—Orlistat—type 2 diabetes mellitus	8.75e-05	0.000478	CcSEcCtD
Etonogestrel—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.74e-05	0.000477	CcSEcCtD
Etonogestrel—Pruritus—Valsartan—type 2 diabetes mellitus	8.74e-05	0.000477	CcSEcCtD
Etonogestrel—Decreased appetite—Losartan—type 2 diabetes mellitus	8.68e-05	0.000474	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.68e-05	0.000474	CcSEcCtD
Etonogestrel—Pruritus—Orlistat—type 2 diabetes mellitus	8.63e-05	0.000471	CcSEcCtD
Etonogestrel—Levonorgestrel—CYP3A4—type 2 diabetes mellitus	8.63e-05	0.0159	CrCbGaD
Etonogestrel—Fatigue—Losartan—type 2 diabetes mellitus	8.61e-05	0.00047	CcSEcCtD
Etonogestrel—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.56e-05	0.000467	CcSEcCtD
Etonogestrel—Oedema—Ramipril—type 2 diabetes mellitus	8.56e-05	0.000467	CcSEcCtD
Etonogestrel—Vomiting—Gliclazide—type 2 diabetes mellitus	8.54e-05	0.000466	CcSEcCtD
Etonogestrel—Constipation—Losartan—type 2 diabetes mellitus	8.54e-05	0.000466	CcSEcCtD
Etonogestrel—Pain—Losartan—type 2 diabetes mellitus	8.54e-05	0.000466	CcSEcCtD
Etonogestrel—Rash—Gliclazide—type 2 diabetes mellitus	8.47e-05	0.000462	CcSEcCtD
Etonogestrel—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.47e-05	0.000462	CcSEcCtD
Etonogestrel—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.45e-05	0.000461	CcSEcCtD
Etonogestrel—Urticaria—Irbesartan—type 2 diabetes mellitus	8.43e-05	0.00046	CcSEcCtD
Etonogestrel—Headache—Gliclazide—type 2 diabetes mellitus	8.42e-05	0.00046	CcSEcCtD
Etonogestrel—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000458	CcSEcCtD
Etonogestrel—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.39e-05	0.000458	CcSEcCtD
Etonogestrel—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.39e-05	0.000458	CcSEcCtD
Etonogestrel—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.35e-05	0.000456	CcSEcCtD
Etonogestrel—Skin disorder—Ramipril—type 2 diabetes mellitus	8.32e-05	0.000454	CcSEcCtD
Etonogestrel—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.23e-05	0.000449	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.17e-05	0.000446	CcSEcCtD
Etonogestrel—Dizziness—Valsartan—type 2 diabetes mellitus	8.16e-05	0.000446	CcSEcCtD
Etonogestrel—Anorexia—Ramipril—type 2 diabetes mellitus	8.16e-05	0.000445	CcSEcCtD
Etonogestrel—CYP3A4—liver—type 2 diabetes mellitus	8.09e-05	0.0167	CbGeAlD
Etonogestrel—Dizziness—Orlistat—type 2 diabetes mellitus	8.07e-05	0.00044	CcSEcCtD
Etonogestrel—Asthenia—Metformin—type 2 diabetes mellitus	8.07e-05	0.00044	CcSEcCtD
Etonogestrel—Nausea—Gliclazide—type 2 diabetes mellitus	7.98e-05	0.000436	CcSEcCtD
Etonogestrel—Pruritus—Metformin—type 2 diabetes mellitus	7.95e-05	0.000434	CcSEcCtD
Etonogestrel—Urticaria—Losartan—type 2 diabetes mellitus	7.93e-05	0.000433	CcSEcCtD
Etonogestrel—Body temperature increased—Losartan—type 2 diabetes mellitus	7.89e-05	0.000431	CcSEcCtD
Etonogestrel—Abdominal pain—Losartan—type 2 diabetes mellitus	7.89e-05	0.000431	CcSEcCtD
Etonogestrel—Danazol—CYP3A4—type 2 diabetes mellitus	7.86e-05	0.0145	CrCbGaD
Etonogestrel—Vomiting—Valsartan—type 2 diabetes mellitus	7.85e-05	0.000428	CcSEcCtD
Etonogestrel—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.82e-05	0.000427	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.8e-05	0.000426	CcSEcCtD
Etonogestrel—Rash—Valsartan—type 2 diabetes mellitus	7.78e-05	0.000425	CcSEcCtD
Etonogestrel—Dermatitis—Valsartan—type 2 diabetes mellitus	7.78e-05	0.000425	CcSEcCtD
Etonogestrel—Vomiting—Orlistat—type 2 diabetes mellitus	7.76e-05	0.000423	CcSEcCtD
Etonogestrel—Insomnia—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000423	CcSEcCtD
Etonogestrel—Headache—Valsartan—type 2 diabetes mellitus	7.73e-05	0.000422	CcSEcCtD
Etonogestrel—Diarrhoea—Metformin—type 2 diabetes mellitus	7.69e-05	0.00042	CcSEcCtD
Etonogestrel—Rash—Orlistat—type 2 diabetes mellitus	7.69e-05	0.00042	CcSEcCtD
Etonogestrel—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.69e-05	0.00042	CcSEcCtD
Etonogestrel—Dermatitis—Orlistat—type 2 diabetes mellitus	7.69e-05	0.000419	CcSEcCtD
Etonogestrel—Headache—Orlistat—type 2 diabetes mellitus	7.64e-05	0.000417	CcSEcCtD
Etonogestrel—Asthenia—Irbesartan—type 2 diabetes mellitus	7.61e-05	0.000416	CcSEcCtD
Etonogestrel—Somnolence—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000415	CcSEcCtD
Etonogestrel—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000411	CcSEcCtD
Etonogestrel—Pruritus—Irbesartan—type 2 diabetes mellitus	7.51e-05	0.00041	CcSEcCtD
Etonogestrel—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.44e-05	0.000406	CcSEcCtD
Etonogestrel—Dizziness—Metformin—type 2 diabetes mellitus	7.44e-05	0.000406	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000403	CcSEcCtD
Etonogestrel—Fatigue—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000403	CcSEcCtD
Etonogestrel—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.36e-05	0.000402	CcSEcCtD
Etonogestrel—Nausea—Valsartan—type 2 diabetes mellitus	7.33e-05	0.0004	CcSEcCtD
Etonogestrel—Constipation—Ramipril—type 2 diabetes mellitus	7.32e-05	0.0004	CcSEcCtD
Etonogestrel—Ethinyl Estradiol—CYP3A4—type 2 diabetes mellitus	7.27e-05	0.0134	CrCbGaD
Etonogestrel—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.26e-05	0.000396	CcSEcCtD
Etonogestrel—Nausea—Orlistat—type 2 diabetes mellitus	7.25e-05	0.000396	CcSEcCtD
Etonogestrel—Asthenia—Losartan—type 2 diabetes mellitus	7.16e-05	0.000391	CcSEcCtD
Etonogestrel—Vomiting—Metformin—type 2 diabetes mellitus	7.15e-05	0.00039	CcSEcCtD
Etonogestrel—Rash—Metformin—type 2 diabetes mellitus	7.09e-05	0.000387	CcSEcCtD
Etonogestrel—Dermatitis—Metformin—type 2 diabetes mellitus	7.08e-05	0.000387	CcSEcCtD
Etonogestrel—Pruritus—Losartan—type 2 diabetes mellitus	7.06e-05	0.000386	CcSEcCtD
Etonogestrel—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000385	CcSEcCtD
Etonogestrel—Headache—Metformin—type 2 diabetes mellitus	7.04e-05	0.000384	CcSEcCtD
Etonogestrel—Dizziness—Irbesartan—type 2 diabetes mellitus	7.02e-05	0.000383	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7e-05	0.000382	CcSEcCtD
Etonogestrel—Norethindrone—CYP3A4—type 2 diabetes mellitus	6.99e-05	0.0129	CrCbGaD
Etonogestrel—Diarrhoea—Losartan—type 2 diabetes mellitus	6.83e-05	0.000373	CcSEcCtD
Etonogestrel—Urticaria—Ramipril—type 2 diabetes mellitus	6.8e-05	0.000371	CcSEcCtD
Etonogestrel—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.77e-05	0.000369	CcSEcCtD
Etonogestrel—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.77e-05	0.000369	CcSEcCtD
Etonogestrel—Vomiting—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000368	CcSEcCtD
Etonogestrel—Rash—Irbesartan—type 2 diabetes mellitus	6.69e-05	0.000365	CcSEcCtD
Etonogestrel—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000365	CcSEcCtD
Etonogestrel—Nausea—Metformin—type 2 diabetes mellitus	6.68e-05	0.000365	CcSEcCtD
Etonogestrel—Headache—Irbesartan—type 2 diabetes mellitus	6.65e-05	0.000363	CcSEcCtD
Etonogestrel—Methyltestosterone—CYP3A4—type 2 diabetes mellitus	6.64e-05	0.0122	CrCbGaD
Etonogestrel—Dizziness—Losartan—type 2 diabetes mellitus	6.6e-05	0.00036	CcSEcCtD
Etonogestrel—Vomiting—Losartan—type 2 diabetes mellitus	6.35e-05	0.000347	CcSEcCtD
Etonogestrel—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000344	CcSEcCtD
Etonogestrel—Nausea—Irbesartan—type 2 diabetes mellitus	6.3e-05	0.000344	CcSEcCtD
Etonogestrel—Rash—Losartan—type 2 diabetes mellitus	6.3e-05	0.000344	CcSEcCtD
Etonogestrel—Dermatitis—Losartan—type 2 diabetes mellitus	6.29e-05	0.000343	CcSEcCtD
Etonogestrel—Headache—Losartan—type 2 diabetes mellitus	6.26e-05	0.000341	CcSEcCtD
Etonogestrel—Asthenia—Ramipril—type 2 diabetes mellitus	6.14e-05	0.000335	CcSEcCtD
Etonogestrel—Norethindrone—ALB—type 2 diabetes mellitus	6.1e-05	0.0112	CrCbGaD
Etonogestrel—Pruritus—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000331	CcSEcCtD
Etonogestrel—Nausea—Losartan—type 2 diabetes mellitus	5.93e-05	0.000324	CcSEcCtD
Etonogestrel—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.86e-05	0.00032	CcSEcCtD
Etonogestrel—Methyltestosterone—ALB—type 2 diabetes mellitus	5.79e-05	0.0107	CrCbGaD
Etonogestrel—Dizziness—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000309	CcSEcCtD
Etonogestrel—Vomiting—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000297	CcSEcCtD
Etonogestrel—Rash—Ramipril—type 2 diabetes mellitus	5.4e-05	0.000295	CcSEcCtD
Etonogestrel—Dermatitis—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000294	CcSEcCtD
Etonogestrel—Headache—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000293	CcSEcCtD
Etonogestrel—Nausea—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000278	CcSEcCtD
Etonogestrel—Testosterone—CYP3A4—type 2 diabetes mellitus	3.85e-05	0.00709	CrCbGaD
Etonogestrel—Testosterone—ALB—type 2 diabetes mellitus	3.36e-05	0.00618	CrCbGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	2.78e-05	0.000684	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	2.71e-05	0.000666	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GRK5—type 2 diabetes mellitus	2.65e-05	0.000653	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GIPR—type 2 diabetes mellitus	2.65e-05	0.000653	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	2.63e-05	0.000646	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—CDKN2B—type 2 diabetes mellitus	2.62e-05	0.000644	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	2.6e-05	0.000639	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—SIRT1—type 2 diabetes mellitus	2.59e-05	0.000637	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IAPP—type 2 diabetes mellitus	2.58e-05	0.000635	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—INSR—type 2 diabetes mellitus	2.57e-05	0.000631	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TRPC6—type 2 diabetes mellitus	2.52e-05	0.00062	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AGTR2—type 2 diabetes mellitus	2.51e-05	0.000616	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.48e-05	0.000611	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.44e-05	0.000599	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MC4R—type 2 diabetes mellitus	2.43e-05	0.000597	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HNF4A—type 2 diabetes mellitus	2.41e-05	0.000592	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EDNRB—type 2 diabetes mellitus	2.4e-05	0.00059	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GIP—type 2 diabetes mellitus	2.34e-05	0.000575	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.33e-05	0.000573	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.33e-05	0.000573	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.32e-05	0.000571	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NR3C1—type 2 diabetes mellitus	2.3e-05	0.000565	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PPP2CA—type 2 diabetes mellitus	2.29e-05	0.000563	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.27e-05	0.000557	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.26e-05	0.000555	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—IL6—type 2 diabetes mellitus	2.25e-05	0.000553	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LEPR—type 2 diabetes mellitus	2.22e-05	0.000546	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.22e-05	0.000545	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.21e-05	0.000543	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.21e-05	0.000543	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.18e-05	0.000537	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	2.17e-05	0.000534	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.16e-05	0.000531	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PPARA—type 2 diabetes mellitus	2.15e-05	0.00053	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.13e-05	0.000524	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	2.12e-05	0.000522	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—DNMT1—type 2 diabetes mellitus	2.1e-05	0.000517	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PSMD6—type 2 diabetes mellitus	2.1e-05	0.000517	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	2.08e-05	0.000513	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—AKT1—type 2 diabetes mellitus	2.07e-05	0.00051	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—CTGF—type 2 diabetes mellitus	2.06e-05	0.000508	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TLE4—type 2 diabetes mellitus	2.06e-05	0.000508	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.05e-05	0.000505	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GCG—type 2 diabetes mellitus	2.02e-05	0.000497	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.02e-05	0.000497	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.99e-05	0.000489	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	1.99e-05	0.000489	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.98e-05	0.000487	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	1.96e-05	0.000481	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	1.92e-05	0.000472	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH2—type 2 diabetes mellitus	1.79e-05	0.00044	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PPARG—type 2 diabetes mellitus	1.78e-05	0.000438	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	1.77e-05	0.000436	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.76e-05	0.000432	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	1.76e-05	0.000432	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	1.76e-05	0.000432	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.74e-05	0.000428	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.73e-05	0.000425	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.72e-05	0.000422	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AVP—type 2 diabetes mellitus	1.72e-05	0.000422	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.71e-05	0.000421	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.71e-05	0.000421	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.71e-05	0.000421	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.7e-05	0.000419	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.68e-05	0.000414	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—AR—type 2 diabetes mellitus	1.67e-05	0.00041	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APOB—type 2 diabetes mellitus	1.66e-05	0.000408	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.65e-05	0.000407	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.65e-05	0.000405	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.63e-05	0.000402	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.6e-05	0.000394	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—LPL—type 2 diabetes mellitus	1.59e-05	0.00039	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.55e-05	0.000382	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.54e-05	0.000378	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.52e-05	0.000375	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.52e-05	0.000374	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.52e-05	0.000373	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—INSR—type 2 diabetes mellitus	1.51e-05	0.00037	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.49e-05	0.000366	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.48e-05	0.000364	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.47e-05	0.000362	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.46e-05	0.000359	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.44e-05	0.000354	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.44e-05	0.000354	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—C3—type 2 diabetes mellitus	1.43e-05	0.000351	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.41e-05	0.000346	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.37e-05	0.000336	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.37e-05	0.000336	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.37e-05	0.000336	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.37e-05	0.000336	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.36e-05	0.000335	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.36e-05	0.000334	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AGT—type 2 diabetes mellitus	1.36e-05	0.000334	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NR3C1—type 2 diabetes mellitus	1.35e-05	0.000332	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.34e-05	0.00033	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.33e-05	0.000328	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.33e-05	0.000327	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APOE—type 2 diabetes mellitus	1.33e-05	0.000327	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—LEP—type 2 diabetes mellitus	1.33e-05	0.000327	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.32e-05	0.000326	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.31e-05	0.000323	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.3e-05	0.00032	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.3e-05	0.00032	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.3e-05	0.000319	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.3e-05	0.000319	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.28e-05	0.000315	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PPARA—type 2 diabetes mellitus	1.26e-05	0.000311	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.25e-05	0.000308	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.21e-05	0.000297	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.2e-05	0.000296	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.2e-05	0.000296	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.19e-05	0.000292	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.19e-05	0.000292	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.19e-05	0.000292	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.17e-05	0.000287	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.16e-05	0.000286	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.16e-05	0.000286	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.16e-05	0.000286	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.16e-05	0.000286	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.16e-05	0.000286	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.16e-05	0.000286	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—INS—type 2 diabetes mellitus	1.14e-05	0.000279	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.12e-05	0.000277	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.12e-05	0.000275	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.1e-05	0.00027	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.1e-05	0.00027	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.06e-05	0.000261	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.06e-05	0.000261	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PPARG—type 2 diabetes mellitus	1.04e-05	0.000257	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.04e-05	0.000256	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.03e-05	0.000255	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.03e-05	0.000254	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.02e-05	0.000251	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.01e-05	0.000248	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.01e-05	0.000248	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1e-05	0.000247	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.99e-06	0.000246	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.96e-06	0.000245	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.96e-06	0.000245	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	9.87e-06	0.000243	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	9.87e-06	0.000243	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	9.87e-06	0.000243	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APOB—type 2 diabetes mellitus	9.74e-06	0.00024	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.7e-06	0.000239	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.59e-06	0.000236	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	9.47e-06	0.000233	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	9.47e-06	0.000233	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—SERPINE1—type 2 diabetes mellitus	9.41e-06	0.000231	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RELA—type 2 diabetes mellitus	9.37e-06	0.00023	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LPL—type 2 diabetes mellitus	9.3e-06	0.000229	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	9.11e-06	0.000224	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	9.11e-06	0.000224	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.11e-06	0.000224	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	8.95e-06	0.00022	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	8.8e-06	0.000216	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	8.8e-06	0.000216	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	8.8e-06	0.000216	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.73e-06	0.000215	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.57e-06	0.000211	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.45e-06	0.000208	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—C3—type 2 diabetes mellitus	8.38e-06	0.000206	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	8.27e-06	0.000203	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.99e-06	0.000196	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.99e-06	0.000196	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.97e-06	0.000196	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AGT—type 2 diabetes mellitus	7.96e-06	0.000196	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.9e-06	0.000194	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.83e-06	0.000192	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APOE—type 2 diabetes mellitus	7.8e-06	0.000192	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LEP—type 2 diabetes mellitus	7.8e-06	0.000192	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.75e-06	0.000191	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.71e-06	0.00019	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.48e-06	0.000184	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.48e-06	0.000184	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.48e-06	0.000184	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.48e-06	0.000184	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SRC—type 2 diabetes mellitus	7.36e-06	0.000181	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.35e-06	0.000181	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	7.17e-06	0.000176	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.17e-06	0.000176	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—AKT1—type 2 diabetes mellitus	7.04e-06	0.000173	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.96e-06	0.000171	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.67e-06	0.000164	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—INS—type 2 diabetes mellitus	6.66e-06	0.000164	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.58e-06	0.000162	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.56e-06	0.000161	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.45e-06	0.000159	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.44e-06	0.000158	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.44e-06	0.000158	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.23e-06	0.000153	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.12e-06	0.000151	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.1e-06	0.00015	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.1e-06	0.00015	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.98e-06	0.000147	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.94e-06	0.000146	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.94e-06	0.000146	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.94e-06	0.000146	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.91e-06	0.000145	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.84e-06	0.000144	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.84e-06	0.000144	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.8e-06	0.000143	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.73e-06	0.000141	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.5e-06	0.000135	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.33e-06	0.000131	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.33e-06	0.000131	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.33e-06	0.000131	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.23e-06	0.000129	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.19e-06	0.000128	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.08e-06	0.000125	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.96e-06	0.000122	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL6—type 2 diabetes mellitus	4.96e-06	0.000122	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.88e-06	0.00012	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.82e-06	0.000119	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.82e-06	0.000119	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.69e-06	0.000115	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.64e-06	0.000114	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.62e-06	0.000114	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.62e-06	0.000114	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.58e-06	0.000113	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.32e-06	0.000106	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.21e-06	0.000104	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—AKT1—type 2 diabetes mellitus	4.13e-06	0.000102	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.98e-06	9.8e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.98e-06	9.8e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.97e-06	9.75e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.91e-06	9.62e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.86e-06	9.5e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.8e-06	9.34e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.79e-06	9.32e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.7e-06	9.09e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.63e-06	8.92e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.55e-06	8.73e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.54e-06	8.7e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.45e-06	8.48e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.4e-06	8.37e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.27e-06	8.03e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.2e-06	7.88e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.1e-06	7.63e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.05e-06	7.5e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.04e-06	7.48e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.01e-06	7.39e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.91e-06	7.16e-05	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.69e-06	6.61e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.65e-06	6.51e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.6e-06	6.39e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.38e-06	5.86e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.28e-06	5.6e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.28e-06	5.6e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.08e-06	5.12e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.05e-06	2.57e-05	CbGpPWpGaD
